A regulatory role for protease-activated receptor-2 in motivational learning in rats

被引:18
|
作者
Lohman, Rink-Jan [1 ,2 ]
Jones, Nigel C. [2 ]
O'Brien, Terence J. [2 ]
Cocks, Thomas M. [1 ]
机构
[1] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3052, Australia
基金
英国医学研究理事会;
关键词
Protease-activated receptor-2; PAR2; SLIGRL; Trypsin; Protease; Learning; Memory; Anxiety; Elevated-plus maze; Morris water maze; Cerebrospinal fluid; TISSUE-PLASMINOGEN-ACTIVATOR; ELEVATED PLUS-MAZE; LONG-TERM POTENTIATION; ANXIETY-LIKE BEHAVIOR; ONE-TRIAL TOLERANCE; BASOLATERAL AMYGDALA; SYNAPTIC PLASTICITY; MOUSE HIPPOCAMPUS; LATE-PHASE; OPEN-FIELD;
D O I
10.1016/j.nlm.2009.03.010
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Serine proteases such as tissue plasminogen activator (tPA), thrombin and neuropsin influence hippocampal plasticity involved in learning and memory by facilitating both synaptic remodelling and long-term potentiation. Given our previous findings that trypsin and its receptor, protease-activated receptor-2 (PAR2), are both highly expressed in pyramidal neurons of the hippocampus and that activation of PAR2 attenuates 'pathogenic' plasticity related to epilepsy, we wished to determine the role for PAR2 in normal, non-pathological hippocampal plasticity related to learning and memory. In a strain of rat that show high basal levels of anxiety, the Genetic Absence Epilepsy Rats from Strasbourg (GAERS), peripheral administration of the PAR2 peptide agonist, SLIGRL (1.5 mg/kg s.c.), induced distinct deficits in experience-dependent learning both in the test-retest paradigm of the elevated-plus maze and in the Morris water maze. In separate, conscious rats with indwelling intra-cerebroventricular cannulae, SLIGRL rapidly appeared in cerebrospinal fluid (CSF) following peripheral administration and had a half-life in CSF of approximately 25 min. These results suggest that activation of central PAR2 with brain accessible peptide agonists causes a temporary deficit in the formation and/or recollection of experience-dependent learning and memory. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:301 / 309
页数:9
相关论文
共 50 条
  • [31] Protease-activated receptor-2: Role in asthma pathogenesis and utility as a biomarker of disease severity
    Gandhi, Vivek Dipak
    Palikhe, Nami Shrestha
    Vliagoftis, Harissios
    FRONTIERS IN MEDICINE, 2022, 9
  • [32] A role for protease-activated receptor-2 in thrombin-mediated cytoprotection of vascular endothelium
    Lidington, EA
    Steinberg, R
    Kinderlerer, A
    Landis, C
    Ohba, M
    Samarel, A
    Haskard, DO
    Mason, JC
    RHEUMATOLOGY, 2005, 44 : I21 - I22
  • [33] A pivotal role of protease-activated receptor-2 in bleomycin-induced pulmonary fibrosis
    Borensztajn, K. S.
    Bresser, P.
    von der Thusen, J.
    van den Blink, B.
    Groot, A. P.
    Daalhuisen, J.
    Peppelenbosch, M. P.
    Spek, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 241 - 241
  • [34] Protease-activated receptor-2 activation -: A major role in the pathogenesis of Porphyromonas gingivalis infection
    Holzhausen, M
    Spolidorio, LC
    Ellen, RP
    Jobin, MC
    Steinhoff, M
    Andrade-Gordon, P
    Vergnolle, N
    AMERICAN JOURNAL OF PATHOLOGY, 2006, 168 (04): : 1189 - 1199
  • [35] Pivotal role of Protease-activated receptor-2 in bleomycin-induced pulmonary fibrosis
    Borensztajn, Keren Sarah
    Bresser, Paul
    von der Thusen, Jan
    van der Loos, Chris
    van der Blink, Bernt
    den Bakker, Michael
    Daalhuisen, Joost
    Groot, Angelique
    Peppelenbosch, Maikel
    Spek, Arnold
    FASEB JOURNAL, 2010, 24
  • [36] PROTEASE-ACTIVATED RECEPTOR-2 (PAR-2) IN THE PATHOGENESIS OF OSTEOARTHRITIS
    Ferrell, William R.
    Kelso, Elizabeth B.
    Lockhart, John C.
    Burns, Elizabeth
    Plevin, Robin
    McInnes, Iain B.
    RHEUMATOLOGY, 2011, 50 : 90 - 90
  • [37] Protease-activated Receptor-2 (PAR2) in Human Periodontitis
    Holzhausen, M.
    Cortelli, J. R.
    Araujo da Silva, V.
    Nobre Franco, G. C.
    Cavalca Cortelli, S.
    Vergnolle, N.
    JOURNAL OF DENTAL RESEARCH, 2010, 89 (09) : 948 - 953
  • [38] Tumour progression and cancer-induced pain: A role for protease-activated receptor-2?
    Kularathna, Pamuditha K.
    Pagel, Charles N.
    Mackie, Eleanor J.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 57 : 149 - 156
  • [39] Protease-activated receptor-2 (PAR2) in cardiovascular system
    Bucci, M
    Roviezzo, F
    Cirino, G
    VASCULAR PHARMACOLOGY, 2005, 43 (04) : 247 - 253
  • [40] Redox regulation of human protease-activated receptor-2 by activated factor X
    Jobi, Klaus
    Rauch, Bernhard H.
    Dangwal, Seema
    Freidel, Kerstin
    Doller, Anke
    Eberhardt, Wolfgang
    Fischer, Jens W.
    Schroer, Karsten
    Rosenkranz, Anke C.
    FREE RADICAL BIOLOGY AND MEDICINE, 2011, 51 (09) : 1758 - 1764